Home/Selank
Complete GuideRussia ApprovedGABA + BDNF

Selank:
Complete Research Guide

Full reference for the Russian-approved peptide anxiolytic โ€” mechanism, clinical trial data, intranasal protocol, safety profile, and COA-verified vendor pricing.

๐Ÿงฌ Class Heptapeptide
โœ… Status Russia Approved
๐Ÿ“… Updated 2026
Jump toOverviewMechanismEvidenceProtocolPricing
โš ๏ธ

Research context only. Selank is approved in Russia. Not FDA-approved. Not medical advice.

Overview

Selank at a Glance

Structure
Heptapeptide (7 AA)
Thr-Lys-Pro-Arg-Pro-Gly-Pro; tuftsin-derived with added stability
Regulatory status
Approved in Russia
Prescribed for anxiety and as nootropic since 1990s. Not FDA-approved.
Primary effect
Anxiolytic + Nootropic
Reduces anxiety without sedation; improves cognitive performance
Preferred route
Intranasal
Fast CNS penetration via olfactory pathway; 15โ€“30 min onset
Mechanism

GABA Modulation + BDNF

Selank's dual mechanism โ€” GABA-A modulation plus BDNF upregulation โ€” produces a profile unlike any conventional anxiolytic. GABA modulation reduces anxiety; BDNF enhancement improves cognition. The combination of effects (anxiolysis + cognitive enhancement) is pharmacologically unusual and clinically valuable.

The GABA mechanism is selective โ€” it doesn't produce the broad GABAergic enhancement that causes sedation and dependence with benzodiazepines. This selectivity is supported by the clinical absence of dependence, withdrawal, and cognitive impairment in Russian prescribing data.

Enkephalin stabilization (via enkephalinase inhibition) adds a third pathway โ€” endogenous opioid peptides modulate stress responses and emotional reactivity through mechanisms separate from the GABA system.

Evidence

Research Summary

ApplicationEvidence LevelKey Findings
Generalized anxietyRussian clinical trialsComparable efficacy to benzodiazepines; superior tolerability profile
Cognitive functionRussian + Western animalImproved working memory, attention, learning in multiple models
Stress responseAnimal modelsReduced corticosterone, normalized stress biomarkers
Immune functionPreclinicalImmune-modulating via tuftsin-derived activity
Dependence / withdrawalClinical dataNo physical dependence; no withdrawal syndrome in clinical use
Protocol

Research Protocol

ParameterValueNotes
Intranasal dose250โ€“1,000 mcgPer administration; 2โ€“3x daily in clinical protocols
SubQ dose250โ€“3,000 mcgOnce daily SubQ if nasal route not preferred
Cycle10โ€“14 days on/offClinical protocols: 10โ€“14 days, then equal rest period
Onset (intranasal)15โ€“30 minutesFaster than SubQ; preferred for acute anxiety use
StackSemax commonSelank + Semax is the standard Russian nootropic stack
Pricing

Verified Vendor Pricing

View Selank Pricing & Protocol

COA-verified vendor pricing with promo codes and reconstitution guide.

View Pricing โ†’ Dosage Calculator